Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0648

+8.0%

3:24 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Howard Williams	11/8/2013 8:16:03 AM
	2 Recommendations Recommended By Jack Russell Khris Smith of 13111

The proxy for the Dec. 16th Special Meeting is available. Interesting stuff in it. sec.gov Here, IMO, is a VERY important statement on page 9 of the proxy, under "Reasons for the Amendment" ..... "In particular, the Company’s drug product candidates (pharmaceutical preparations) in both the oncology and dermatology therapeutic areas have been shown through recent research to harness the immune system of those patients treated to aid in reducing their tumor burden in various cancer indications and to reduce the inflammation of those patients treated with various inflammatory dermatoses. Both of these approaches to treat disease relate to properly utilizing the patient’s biologic or immune system and not just the direct treatment of his or her disease." Think about that. That is very specific, a statement of fact. No ambiguity. "have been shown" That is well beyond words like "under investigation" or "potentially" or "is showing promise". "have been shown" Stated in an SEC filing.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next